Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	188
Overall Study	STARTED	Xyrem (Sodium Oxybate) 4.5g	195
Overall Study	STARTED	Xyrem (Sodium Oxybate) 6.0g	190
Overall Study	Treated	Placebo	188
Overall Study	Treated	Xyrem (Sodium Oxybate) 4.5g	194
Overall Study	Treated	Xyrem (Sodium Oxybate) 6.0g	189
Overall Study	COMPLETED	Placebo	131
Overall Study	COMPLETED	Xyrem (Sodium Oxybate) 4.5g	129
Overall Study	COMPLETED	Xyrem (Sodium Oxybate) 6.0g	116
Overall Study	NOT COMPLETED	Placebo	57
Overall Study	NOT COMPLETED	Xyrem (Sodium Oxybate) 4.5g	66
Overall Study	NOT COMPLETED	Xyrem (Sodium Oxybate) 6.0g	74

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00423813/flow